1. Home
  2. PLAG vs LNAI Comparison

PLAG vs LNAI Comparison

Compare PLAG & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Green Holdings Corp.

PLAG

Planet Green Holdings Corp.

HOLD

Current Price

$2.99

Market Cap

25.6M

ML Signal

HOLD

Logo Lunai Bioworks Inc.

LNAI

Lunai Bioworks Inc.

N/A

Current Price

$0.23

Market Cap

18.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PLAG
LNAI
Founded
1986
N/A
Country
United States
United States
Employees
6
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.6M
18.3M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
PLAG
LNAI
Price
$2.99
$0.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
99.6K
288.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
32.56
N/A
EPS
N/A
N/A
Revenue
$6,729,937.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$0.36
52 Week High
$4.49
$1.66

Technical Indicators

Market Signals
Indicator
PLAG
LNAI
Relative Strength Index (RSI) 54.03 23.92
Support Level $1.61 N/A
Resistance Level $3.07 $1.09
Average True Range (ATR) 0.47 0.07
MACD -0.02 -0.02
Stochastic Oscillator 79.23 1.22

Price Performance

Historical Comparison
PLAG
LNAI

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: